Parents, educators, politicians, federal regulators, and advocates for Americans’ better health all should pause and consider the prime takeaways from a company’s willingness to strike a $439 million settlement with three dozen states figuratively shutting a barn door long after the nag has bolted. Hint: Big Tobacco is relentless in its efforts to addict regular….
Continue ReadingProduct Safety
When Big Pharma opens its big checkbook, life-saving disclosures vanish
Big Pharma loves to blast away at opposition lawyers and their clients, criticizing them for seeking justice in the civil system over claims of significant harms. But, c’mon, man, as a certain top political leader likes to say to express his flabbergasted skepticism. Wealthy corporations and their counsel marshal enormous, costly legal resources to bully,….
Continue ReadingWhite House conference, first in 50 years, will focus on diet and nutrition
The Biden Administration this month will tackle one of the major, persistent challenges that perplexes and damages the health and well-being of most regular folks: what they eat, as well as their regular sources of food. The scheduled Sept. 28 White House Conference on Hunger, Nutrition, and Health will be only the second of its kind….
Continue ReadingRisks rising for little kids ingesting button- and lithium coin-batteries
As manufacturers press to shrink electronic devices, small children across the country are getting put at high risk of big harms by swallowing small button- and lithium coin-batteries, research shows. The round, shiny, and ubiquitous batteries have proven to be irresistible to the pint-sized and curious, who gulp them down after they find them scattered….
Continue ReadingGen Z becomes stoner generation with record-high pot and hallucinogen use
Generation Z and young millennials have become the nation’s leading group of stoners, setting record highs for their use of marijuana, hallucinogenic drugs, nicotine, and booze. This has occurred even as federal regulators have gotten called out for failing to crack down, after chest-thumping promises to do so, on the noxious but popular practice among….
Continue Reading$1.7 billion verdict underscores complexity of vehicle liability cases
Even the strongest believer in the wisdom of juries in civil lawsuits had to take a pause. But, yes, the verdict in an Atlanta case has been correctly reported. Jurors deliberating on the damages caused in roll-over of a Ford 250 truck did, indeed, order the automaker to pay the family of two people killed….
Continue Reading3 giant drug store chains hit with $650-million judgment for opioid harms
CVS, Walgreens, and Walmart are getting expensive lessons about corporate responsibility in filling prescriptions, as federal courts in San Francisco and Cleveland separately have faulted the companies for inundating communities with staggering quantities of addictive painkillers. Those drugs caused such great harm that the three major drug chains must pay two Ohio Counties $650.5 million,….
Continue ReadingWhen claims of harms rise, more corporations are diving into bankruptcy
They were a tortured part of the opioid abuse and drug overdose crisis. They have become a painful aspect of the push to hold nursing home owners and operators accountable for the shambolic response to the coronavirus pandemic. And they soon may be an obstacle to military veterans’ attempts to get justice for defective devices….
Continue ReadingDiabetes drugs that cause weight loss find plus-size online demand
They’re expensive and often uncovered by health insurance. They’re unfamiliar for now to many doctors, especially those in primary care. But — as expected — patients are hearing a lot about the effectiveness of new prescription medications aimed at treating diabetes and how these drugs have another positive outcome: They help users lose weight, potentially….
Continue ReadingA top FDA tobacco expert suddenly quits — to work for Big Tobacco
The ink was barely dry on statements from the head of the federal Food and Drug Administration about a planned external, independent review of the agency’s tobacco oversight division when one of its top regulators created a personnel stink of his own. Matt Holman, chief of the office of science in FDA’s much-criticized Center for….
Continue Reading